Back to Agenda
Session 3a: Change Management – From Insights Into Action
Session Chair(s)
Dyan Bryson
VP, Diversity Services
TOTAL Diversity Clinical Trial Management, United States
What does it take for a company to achieve change management on diversity and inclusion (D&I) efforts? What is the momentum needed within a company to take on D&I efforts? What tools and resources currently exist? How does one engage with the CEO and leadership on these efforts? These questions and more will be explored as you join experts who have tackled these challenges and will provide solutions that work towards change management best practices of D&I efforts, driving insights into action.
Learning Objective : - Understand the conscious decision making it takes for a company to pursue diversity in clinical trials
- Describe the steps it takes to truly put the patient at the center of the business
- Contribute to internal discussions to manage the challenges of enhancing diversity in clinical trials
- Understand that enhancing clinical trials and being patient centered are two inseparable concepts
Speaker(s)
Business Model Evolution – Putting the Patient at the Center
Anthony Yanni, MD, MBA
Astellas, United States
SVP, Patient Centricity
Getting it Done: Clinical Trial Diversity
Jessica S. Scott, JD, MD
Legacy Health Strategies , United States
President
Getting it Done: Clinical Trial Diversity
Donna Schwarz
Schwarz Consultants, United States
Founder
Clinical Trial Diversity: The Supplier Perspective
Adam Brown
Clinark, United States
Founder and CEO
Clinical Trial Diversity: The Supplier Perspective
Danielle Mitchell
Black Women in Clinical Research, United States
CEO and Founder
Clinical Trial Diversity: The Supplier Perspective
Marya Shegog, MPH
The Lazarus Project, United States
Health Equity and Diversity Coordinator
Business Model Evolution – Putting the Patient at the Center
Douglas Noland, MBA
Astellas, United States
Head of Patient Partnerships, Executive Director
Have an account?